The Danish National Board of Health has changed its recommendation to one dose of Pandemrix® vaccine against influenza A (H1N1)v for healthy adults who are offered the vaccine. However, all persons in the risk groups should still be given the vaccine in two doses.
The change is based on a recommendation by the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMEA).
In the factbox to the right you can find the Danish National Board of Health’s announcement (in Danish only) and the CHMP’s recommendation.
For further information, please contact Chief Medical Officer Steffen Thirstrup, tel. +45 4488 9187 or +45 2246 7811.
Danish Medicines Agency, 23 October 2009